No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (1)
AQR
$116.0M
added
Sells/Trims (2)
Qube Research
$36.9M
sold
Point72
$34.3M
sold
Buys (1)
Peribere Jerome A
$141K
bought
Sells (1)
Mcshane Geri-Michelle
$501K
sold
No tracked top-trader positions in XYL as of Oct 24, 09:34 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Jul 28, 2026
Financial period
Q2 2026
Earnings per share
$1.34 expected
Revenue
Company release
FY2026 guidance
$9.20B
No comparable estimate
Estimates as of Oct 24, 2026
EPS expected
$1.40 to $1.53
Revenue expected
16 analysts
Last 30 days
Analysts cutting estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 28, 2026 | $1.46 / $1.34Alpha Vantage | +8.96% beat | $2.34B No estimate | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | $1.12 / $1.08Alpha Vantage | +3.70% beat | $2.13B No estimate | Unavailable |
| Dec 31, 2025 | Feb 10, 2026 | $1.42 / $1.41Alpha Vantage | +0.71% in line | $2.40B No estimate | Unavailable |
| Sep 30, 2025 | Oct 28, 2025 | $1.37 / $1.23Alpha Vantage | +11.38% beat | $2.27B No estimate | Unavailable |
| Jun 30, 2025 | Jul 31, 2025 | $1.26 / $1.15Alpha Vantage | +9.57% beat | $2.30B No estimate | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | $1.03 / $0.95Alpha Vantage | +8.42% beat | $2.07B No estimate | Unavailable |
| Dec 31, 2024 | Feb 4, 2025 | $1.18 / $1.13Alpha Vantage | +4.42% beat | $2.26B No estimate | Unavailable |
| Sep 30, 2024 | Oct 31, 2024 | $1.11 / $1.11Alpha Vantage | +0.00% in line | $2.10B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.27B | $2.40B | $2.13B | $2.34B |
| Cost of what it sold | $1.39B | $1.47B | $1.32B | $1.37B |
| Gross profit | $883.0M | $932.0M | $803.0M | $963.0M |
| What it spent | ||||
| Research and development | $52.0M | $60.0M | $56.0M | $59.0M |
| Sales and admin | $474.0M | $486.0M | $472.0M | $503.0M |
| Other operating costs | $23.0M | $33.0M | $31.0M | $11.0M |
| Total operating expenses | $549.0M | $579.0M | $559.0M | $573.0M |
| What was left | ||||
| Operating profit | $334.0M | $353.0M | $244.0M | $390.0M |
| Interest on debt | $6.0M | $6.0M | $4.0M | $7.0M |
| Profit before tax | $297.0M | $368.0M | $244.0M | $364.0M |
| Tax | $71.0M | $35.0M | $55.0M | $103.0M |
| Net profit | $227.0M | $335.0M | $185.0M | $263.0M |
| EBITDA | $445.0M | $517.0M | $388.0M | $511.0M |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace